Winston J T Tan1, Lei Song2,3,4, Morven Graham5, Amy Schettino6, Dhasakumar Navaratnam7,8, Wendell G Yarbrough1,9, Joseph Santos-Sacchi1,8,10, Alla V Ivanova1. 1. 1 Department of Surgery, Section of Otolaryngology, Yale University School of Medicine , New Haven, Connecticut. 2. 2 Department of Otolaryngology-Head and Neck Surgery, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, China . 3. 3 Ear Institute, Shanghai Jiao Tong University School of Medicine , Shanghai, China . 4. 4 Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases , Shanghai, China . 5. 5 CCMI EM Core Facility, Yale University School of Medicine , New Haven, Connecticut. 6. 6 Yale School of Medicine , New Haven, Connecticut. 7. 7 Department of Neurology, Yale University School of Medicine , New Haven, Connecticut. 8. 8 Department of Neuroscience, Yale University School of Medicine , New Haven, Connecticut. 9. 9 Department of Pathology, Yale University School of Medicine , New Haven, Connecticut. 10. 10 Department of Cellular and Molecular Physiology, Yale University School of Medicine , New Haven, Connecticut.
Abstract
AIMS: Acquired hearing loss is a worldwide epidemic that affects all ages. It is multifactorial in etiology with poorly characterized molecular mechanisms. Mitochondria are critical components in hearing. Here, we aimed to identify the mechanisms of mitochondria-dependent hearing loss using Fus1 KO mice, our novel model of mitochondrial dysfunction/oxidative stress. RESULTS: Using auditory brainstem responses (ABRs), we characterized the Fus1 KO mouse as a novel, clinically relevant model of age-related hearing loss (ARHL) of metabolic etiology. We demonstrated early decline of the endocochlear potential (EP) that may occur due to severe mitochondrial and vascular pathologies in the Fus1 KO cochlear stria vascularis. We showed that pathological alterations in antioxidant (AO) and nutrient and energy sensing pathways (mTOR and PTEN/AKT) occur in cochleae of young Fus1 KO mice before major hearing loss. Importantly, short-term AO treatment corrected pathological molecular changes, while longer AO treatment restored EP, improved ABR parameters, restored mitochondrial structure, and delayed the development of hearing loss in the aging mouse. INNOVATION: Currently, no molecular mechanisms linked to metabolic ARHL have been identified. We established pathological and molecular mechanisms that link the disease to mitochondrial dysfunction and oxidative stress. CONCLUSION: Since chronic mitochondrial dysfunction is common in many patients, it could lead to developing hearing loss that can be alleviated/rescued by AO treatment. Our study creates a framework for clinical trials and introduces the Fus1 KO model as a powerful platform for developing novel therapeutic strategies to prevent/delay hearing loss associated with mitochondrial dysfunction. Antioxid. Redox Signal. 27, 489-509.
AIMS: Acquired hearing loss is a worldwide epidemic that affects all ages. It is multifactorial in etiology with poorly characterized molecular mechanisms. Mitochondria are critical components in hearing. Here, we aimed to identify the mechanisms of mitochondria-dependent hearing loss using Fus1 KO mice, our novel model of mitochondrial dysfunction/oxidative stress. RESULTS: Using auditory brainstem responses (ABRs), we characterized the Fus1 KO mouse as a novel, clinically relevant model of age-related hearing loss (ARHL) of metabolic etiology. We demonstrated early decline of the endocochlear potential (EP) that may occur due to severe mitochondrial and vascular pathologies in the Fus1 KO cochlear stria vascularis. We showed that pathological alterations in antioxidant (AO) and nutrient and energy sensing pathways (mTOR and PTEN/AKT) occur in cochleae of young Fus1 KO mice before major hearing loss. Importantly, short-term AO treatment corrected pathological molecular changes, while longer AO treatment restored EP, improved ABR parameters, restored mitochondrial structure, and delayed the development of hearing loss in the aging mouse. INNOVATION: Currently, no molecular mechanisms linked to metabolic ARHL have been identified. We established pathological and molecular mechanisms that link the disease to mitochondrial dysfunction and oxidative stress. CONCLUSION: Since chronic mitochondrial dysfunction is common in many patients, it could lead to developing hearing loss that can be alleviated/rescued by AO treatment. Our study creates a framework for clinical trials and introduces the Fus1 KO model as a powerful platform for developing novel therapeutic strategies to prevent/delay hearing loss associated with mitochondrial dysfunction. Antioxid. Redox Signal. 27, 489-509.
Authors: Ana Ortega-Molina; Alejo Efeyan; Elena Lopez-Guadamillas; Maribel Muñoz-Martin; Gonzalo Gómez-López; Marta Cañamero; Francisca Mulero; Joaquin Pastor; Sonia Martinez; Eduardo Romanos; M Mar Gonzalez-Barroso; Eduardo Rial; Angela M Valverde; James R Bischoff; Manuel Serrano Journal: Cell Metab Date: 2012-03-07 Impact factor: 27.287
Authors: Hyo Jeong Kim; Michael Anne Gratton; Jeong-Han Lee; Maria Cristina Perez Flores; Wenying Wang; Karen J Doyle; Friedrich Beermann; Michael A Crognale; Ebenezer N Yamoah Journal: J Neurosci Date: 2013-09-04 Impact factor: 6.167
Authors: Marta Bueno; Yen-Chun Lai; Yair Romero; Judith Brands; Claudette M St Croix; Christelle Kamga; Catherine Corey; Jose D Herazo-Maya; John Sembrat; Janet S Lee; Steve R Duncan; Mauricio Rojas; Sruti Shiva; Charleen T Chu; Ana L Mora Journal: J Clin Invest Date: 2014-12-22 Impact factor: 14.808
Authors: Suzana Gispert; Dajana Parganlija; Michael Klinkenberg; Stefan Dröse; Ilka Wittig; Michel Mittelbronn; Pawel Grzmil; Sebastian Koob; Andrea Hamann; Michael Walter; Finja Büchel; Thure Adler; Martin Hrabé de Angelis; Dirk H Busch; Andreas Zell; Andreas S Reichert; Ulrich Brandt; Heinz D Osiewacz; Marina Jendrach; Georg Auburger Journal: Hum Mol Genet Date: 2013-07-12 Impact factor: 6.150
Authors: Lynda El-Hassar; Lei Song; Winston J T Tan; Charles H Large; Giuseppe Alvaro; Joseph Santos-Sacchi; Leonard K Kaczmarek Journal: J Neurosci Date: 2019-04-01 Impact factor: 6.167
Authors: Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Michael H Irwin; Iphigenia Kanara; Carl A Pinkert; Whitney R Powers; Kosta Steliou; Demetrios G Vavvas; Krishna Kodukula Journal: Biores Open Access Date: 2018-07-01